JIM 2026;
3 (1): e1119
DOI: 10.61012_20262_1119
Medical management and long-term outcome in classical ethylmalonic encephalopathy: insights from a prolonged follow-up
Topic: Inherited Metabolic Diseases in Paediatric Age
Category: Case report
![]()
Abstract
Background: Ethylmalonic encephalopathy (EE) is a rare autosomal recessive metabolic disorder caused by biallelic mutations in the ETHE1 gene, resulting in defective mitochondrial detoxification of hydrogen sulfide (H₂S). The classical form is characterized by early-onset progressive neurological deterioration, multisystem involvement, and poor prognosis, with death typically occurring within the first years of life. Although liver transplantation is currently the only intervention shown to modify disease course, medical therapies aimed at reducing H₂S toxicity – such as metronidazole and N-acetylcysteine (NAC) – are widely used as supportive treatment. However, only limited data are currently available on long-term outcomes under medical therapy.
Case Report: We report a patient with genetically confirmed classical EE and a severe early-onset phenotype who survived into adolescence, showing prolonged clinical stabilization under long-term treatment with metronidazole, NAC, and antioxidant supplementation. Following rapid neurological deterioration in infancy, epilepsy and extra-neurological manifestations, including chronic diarrhea and growth failure, subsequently stabilized. Although biochemical abnormalities persisted and fluctuated over time, they did not show a clear correlation with clinical status.
Conclusions: This case documents an unusually long-term survival in classical EE in the absence of liver transplantation and provides valuable insight into the long-term clinical course under medical management. While stabilization cannot be unequivocally attributed to therapy alone, our observations suggest the potential role of sustained medical treatment – possibly in combination with dietary interventions – as a supportive strategy to slow disease progression and improve quality of life in patients who are not candidates for transplantation or who are awaiting liver transplantation. Systematic collection of longitudinal data is essential to better define prognosis and optimize management in this devastating disorder.
![]()
To cite this article
Medical management and long-term outcome in classical ethylmalonic encephalopathy: insights from a prolonged follow-up
JIM 2026;
3 (1): e1119
DOI: 10.61012_20262_1119
Publication History
Submission date: 07 Jan 2026
Revised on: 21 Jan 2026
Accepted on: 28 Jan 2026
Published online: 27 Feb 2026